Equasens S.A.
0R9T.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$432.08M
Close$
$80.52
180.6% upside
Current Fair Value
180.6% upsideUndervalued by 180.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $432.08 Million |
|---|---|
| Enterprise Value | $493.39 Million |
| Dividend Yield | $1.40 (4.88%) |
| Earnings per Share | $2.62 |
| Beta | 0.56 |
| Outstanding Shares | 15,794,000 |
Return
| Return on Equity | 35.40% |
|---|---|
| Return on Assets | 20.59% |
| Return on Invested Capital | 5.55% |
Valuation & Multiples
| P/E Ratio | 10.63 |
|---|---|
| PEG | -36.25 |
| Price to Sales | 1.06 |
| Price to Book Ratio | 1.91 |
| Enterprise Value to Revenue | 1.13 |
| Enterprise Value to EBIT | 29.96 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$124.50 M
Average shareholder expectationNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Equasens S.A.
1,462 employees
CEO: Denis Supplisson Equasens S.A., founded in 1996 and headquartered in Villers-les-Nancy, France, is a European-based subsidiary of Marque Verte Sante that specializes in providing a wide array of information technology solutions for the healthcare sector....